Bed Bath & Beyond, Inc. short interest in 2023
In 2023, Bed Bath & Beyond, Inc.'s disclosed short interest ran from 12.36% of shares outstanding on 13 Jan 2023 to 12.79% on 31 Oct 2023, a change of +0.43 percentage points. The year's high was 13.63% on 15 Feb 2023 and its low 7.21% on 15 May 2023, averaging 10.84% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.32 days on 31 Jan 2023. Full history: Bed Bath & Beyond, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 12.36% (13 Jan 2023)
- End of year
- 12.79% (31 Oct 2023)
- Change
- +0.43 pp
- High
- 13.63% (15 Feb 2023)
- Low
- 7.21% (15 May 2023)
- Average
- 10.84%
- Highest days to cover
- 4.32 (31 Jan 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 12.36% | 3.61 | |
| 31 Jan 2023 | 11.42% | 4.32 | |
| 15 Feb 2023 | 13.63% | 4.05 | |
| 28 Feb 2023 | 12.79% | 2.99 | results (8-K), 10-K filed |
| 15 Mar 2023 | 11.73% | 3.66 | |
| 31 Mar 2023 | 9.71% | 2.37 | |
| 14 Apr 2023 | 9.37% | 3.10 | |
| 28 Apr 2023 | 9.13% | 3.15 | results (8-K) |
| 15 May 2023 | 7.21% | 3.13 | 10-Q filed |
| 31 May 2023 | 8.01% | 3.48 | |
| 15 Jun 2023 | 7.93% | 2.42 | |
| 30 Jun 2023 | 9.38% | 1.00 | |
| 14 Jul 2023 | 12.15% | 2.17 | |
| 31 Jul 2023 | 11.42% | 1.95 | results (8-K), 10-Q filed |
| 15 Aug 2023 | 11.46% | 2.70 | |
| 31 Aug 2023 | 12.56% | 3.00 | |
| 15 Sep 2023 | 10.53% | 1.33 | |
| 29 Sep 2023 | 13.14% | 3.55 | |
| 13 Oct 2023 | 10.07% | 1.84 | |
| 31 Oct 2023 | 12.79% | 1.84 | results (8-K), 10-Q filed |
See also: Bed Bath & Beyond, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.